Synthesis, crystal structure, DFT calculations, and molecular docking of N-(4-bromophenyl)pyridine-2-carboxamide palladium(II) complexes

IF 2.5 Q2 CHEMISTRY, MULTIDISCIPLINARY
Pinky N. Mjwara , Eric O. Akintemi , Siphamandla Sithebe , Hadley S. Clayton , Tshephiso R. Papo
{"title":"Synthesis, crystal structure, DFT calculations, and molecular docking of N-(4-bromophenyl)pyridine-2-carboxamide palladium(II) complexes","authors":"Pinky N. Mjwara ,&nbsp;Eric O. Akintemi ,&nbsp;Siphamandla Sithebe ,&nbsp;Hadley S. Clayton ,&nbsp;Tshephiso R. Papo","doi":"10.1016/j.rechem.2025.102194","DOIUrl":null,"url":null,"abstract":"<div><div>A novel palladium(II) complex, ([N-(4-bromophenyl)pyridine-2-carboxamidato]-(chloro)-(pyridine)‑palladium, <strong>C2</strong>) was synthesized from an aqueous solution of potassium tetrachloropalladate, pyridine and the <em>N</em>-<!--> <!-->(4-<!--> <!-->bromophenyl)<!--> <!-->pyridine-2-carboxamide ligand. Single crystal X-ray crystallography analysis reveals that the asymmetric units of C<sub>17</sub>H<sub>15</sub>BrClN<sub>3</sub>O<sub>2</sub>Pd belong to the orthorhombic crystal system with the Pbca space group. The experimentally determined structure of <strong>C2</strong> was examined and compared to a previously synthesized analogous bis[N-(4-bromophenyl)pyridine-2-carboxamidato]palladium complex (<strong>C1</strong>) by density functional theory (DFT) and molecular docking studies. DFT b3lyp/3-21g method gave reasonably low optimization energies and band energy value of ∼3.2 eV for both complexes, suggesting they are chemically reactive. Molecular docking simulations through the docking scores show that <strong>C2</strong> (−121.2 and −119.2 kcal/mol) is more potent than <strong>C1</strong> (−73.1 and −106.6 kcal/mol) against prostate and cervical cancers, while <strong>C1</strong> (−78.5 and −108.3 kcal/mol) is more potent than <strong>C2</strong> (−88.5 and −116.5 kcal/mol) against skin and breast cancer. Some key interacting residues in the binding site of prostate cancer protein include Trp227, Phe306, Phe311, and Tyr317. The cervical cancer protein includes Tyr15, Asp127, Val18 and Glu12. For skin cancer protein, they are Arg223, Glu226, Leu227 and Ile224; and for breast cancer protein are Cys2085, Glu2052, Phe2048, and Gln2082. Generally, the Pd(II) complexes show promising anticancer potential and could potentially be a more effective chemotherapeutic than the standard carboplatin drug.</div></div>","PeriodicalId":420,"journal":{"name":"Results in Chemistry","volume":"15 ","pages":"Article 102194"},"PeriodicalIF":2.5000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Results in Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211715625001778","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

A novel palladium(II) complex, ([N-(4-bromophenyl)pyridine-2-carboxamidato]-(chloro)-(pyridine)‑palladium, C2) was synthesized from an aqueous solution of potassium tetrachloropalladate, pyridine and the N- (4- bromophenyl) pyridine-2-carboxamide ligand. Single crystal X-ray crystallography analysis reveals that the asymmetric units of C17H15BrClN3O2Pd belong to the orthorhombic crystal system with the Pbca space group. The experimentally determined structure of C2 was examined and compared to a previously synthesized analogous bis[N-(4-bromophenyl)pyridine-2-carboxamidato]palladium complex (C1) by density functional theory (DFT) and molecular docking studies. DFT b3lyp/3-21g method gave reasonably low optimization energies and band energy value of ∼3.2 eV for both complexes, suggesting they are chemically reactive. Molecular docking simulations through the docking scores show that C2 (−121.2 and −119.2 kcal/mol) is more potent than C1 (−73.1 and −106.6 kcal/mol) against prostate and cervical cancers, while C1 (−78.5 and −108.3 kcal/mol) is more potent than C2 (−88.5 and −116.5 kcal/mol) against skin and breast cancer. Some key interacting residues in the binding site of prostate cancer protein include Trp227, Phe306, Phe311, and Tyr317. The cervical cancer protein includes Tyr15, Asp127, Val18 and Glu12. For skin cancer protein, they are Arg223, Glu226, Leu227 and Ile224; and for breast cancer protein are Cys2085, Glu2052, Phe2048, and Gln2082. Generally, the Pd(II) complexes show promising anticancer potential and could potentially be a more effective chemotherapeutic than the standard carboplatin drug.

Abstract Image

求助全文
约1分钟内获得全文 求助全文
来源期刊
Results in Chemistry
Results in Chemistry Chemistry-Chemistry (all)
CiteScore
2.70
自引率
8.70%
发文量
380
审稿时长
56 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信